Approximately 10% of BC cases harbor a germline mutation in the breast cancer genes 1 (BRCA1) or 2 (BRCA2), (gBRCAm), which affects the homologous repair mechanism of DNA double-strand breaks. This evidence concerns the gene BRCA2 and breast cancer.